ALRISE BIOSYSTEMS GMBH has a total of 18 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, micro-structure and nano-technology and chemical engineering are FOSHAN CITY HONGTAI PHARMACEUTICAL R & D CO LTD, LI SHAOLUN and YIN LIMING.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 2 | |
#5 | Japan | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Micro-structure and nano-technology | |
#3 | Chemical engineering | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Albayrak Celal | 17 |
#2 | Schmitz Reinhard | 1 |
#3 | Roessling Georg | 1 |
#4 | Tack Johannes | 1 |
#5 | Albayrak Celal Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP3372224A1 | New controlled drug delivery system using water miscible solvents for production of drug loaded micro- and nanoparticles | |
US2017231957A1 | Injectable formulations of asenapine | |
EP3307245A1 | Process for the preparation of drug loaded microparticles | |
US2016303102A1 | Process for the production of drug formulations for oral administration | |
EP1344520A1 | Microparticles and method for their production | |
EP1343480A2 | Induced phase transition method for the production of microparticles containing hydrophobic active agents |